The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.

This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Table of contents

  • Asia Pacific (Supplemental)
    • Abstract
    • Version History
    • Interventional Oncology Device Market
      • Market Definitions
        • Geographies Covered
        • Procedures Covered
        • Products Covered
      • Market Forecast Data
    • Ablation Device Market
      • Market Definitions
      • Market Forecast Data
    • Embolization Particle Market
      • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Nithu Mariya Johnson, PharmD

Nithu Mariya Johnson is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and interventional cardiology device markets. Nithu holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Nithu on twitter: @nithu_22


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific

Despite pricing pressures and the release of mixed clinical data, the Asia Pacific interventional oncology device market will expand rapidly through 2027, driven by the continued growth of cance...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe

The European interventional oncology device market will be driven by moderate procedure volume growth, spurred by enhanced cancer detection, rising patient and physician awareness, improved reim...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European interventional oncology device market will be characterized by procedure volume growth, spurred by enhanced reimbursement, product improvements, and the availability of new technolo...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | United States

The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in...

View Details